The Weekly Summary

December 23rd – December 31st                                 2019

In the general news, China jailed the scientist who edited human embryo DNA that developed into actual babies. In the U.S., it was slow over the holiday break. Not even President Trump tweeted much.

In healthcare business news, Roche formed a $1 B deal with Sarepta (SRPT) for DMD drugs. Also, JNJ acquired rights to robotic surgery.

On the data front, Spectrum Pharma (SPPI) shares fell as their lung cancer trial failed.

From the FDA. Allergan (AGN) won approval for Ubrelvy (ubrogepant) to treat migraines.

This entry was posted in - The Weekly Summary. Bookmark the permalink.

Leave a Reply

Your email address will not be published.